RxDoctor Payments Data

Suzanna Fitzpatrick

Acute Care · Baltimore, MDNPI 1629360011

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Smith+Nephew at 25.9% of the total. Among acute care clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,816in general payments, 2019–2025

Across 54 payments — averaging $52.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$728
  • Progenacare Global, LLC$347
  • Organogenesis Inc.$344
  • Tactile Systems Technology Inc$248
  • W. L. Gore & Associates, Inc.$151
  • Boston Scientific$128
  • plus $869 from 17 others

What the payments were for

  • Food & beverage$2,816100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,816 in reported general payments places this provider in the 90th percentile of 502 acute care providers in Maryland.

See all acute care providers in Maryland

Medicare billing

Part B allowed, 2024
$23,289
Medicare patients
118
Services billed
232

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban13$9,271
ClopidogrelClopidogrel Bisulfate13$84
Oxycodone Hcl18$56
Atorvastatin Calcium12$47

Paid to pharmacies, not to this prescriber.

Other acute care in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →